JRCT ID: jRCT1011230058
Registered date:26/01/2024
ALPHABET study
Basic Information
| Recruitment status | Pending |
|---|---|
| Health condition(s) or Problem(s) studied | Overactive bladder with benign prostatic hyperplasia |
| Date of first enrollment | 26/01/2024 |
| Target sample size | 60 |
| Countries of recruitment | |
| Study type | Interventional |
| Intervention(s) | tamusulocin vibegron |
Outcome(s)
| Primary Outcome | OABSS |
|---|---|
| Secondary Outcome | IPSS postvoid residual |
Key inclusion & exclusion criteria
| Age minimum | >= 40age old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male |
| Include criteria | Age over 40 Prostate volume less than 30ml OAB Postvoid residual less than 100ml Patients who agree with the research |
| Exclude criteria | Postvoid residual over 100ml suspected of prostate cancer any medicationfor LUTS within 8 weeks patients with neurogenic disease patients with active urinary infection patients with hypotension patients with severe heart disease patients with severe liver disease pateints with severe kidney disease patients with allergy with tamsulocin/vibegron |
Related Information
| Primary Sponsor | Wada Naoki |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | |
| Secondary ID(s) |
Contact
| Public contact | |
| Name | Naoki Wada |
| Address | 2-1 Higashi Midorigaoka Asahikawa Hokkaido Japan 078-8510 |
| Telephone | +81-166-68-2533 |
| nwada@asahikawa-med.ac.jp | |
| Affiliation | Asahikawa Medical University |
| Scientific contact | |
| Name | Naoki Wada |
| Address | 2-1 Higashi Midorigaoka Asahikawa Hokkaido Japan 078-8510 |
| Telephone | +81-166-68-2533 |
| nwada@asahikawa-med.ac.jp | |
| Affiliation | Asahikawa Medical University |